Shantharam Harish, CFO of ALX Oncology Holdings Inc ($ALXO), made one open market purchase of shares worth $58,402.50 in the last year. His most recent buy occurred on August 18, 2025. This ranks 2,840th among nearly 5,000 insiders, well below the average purchase of $1.46 million across 3.3 transactions. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 26, 2026 | ALX ONCOLOGY HOLDINGS INC | $ALXO | Shantharam Harish | Chief Financial Officer | A | Stock option (right to buy) | 303000 | $0.00 | 303,000.0000 | 54,218,001 | 9999.99% | 0.56% |
| Oct. 14, 2025 | ALX ONCOLOGY HOLDINGS INC | $ALXO | Shantharam Harish | Chief Financial Officer | A | Employee Stock Option (right to buy) | 198750 | $0.00 | 198,750.0000 | 53,384,145 | 9999.99% | 0.37% |
| Aug. 18, 2025 | ALX ONCOLOGY HOLDINGS INC | $ALXO | Shantharam Harish | Chief Financial Officer | P | Common Stock | 75000 | $0.78 | 75,000.0000 | 53,384,145 | 9999.99% | 0.14% |
| April 11, 2025 | ALX ONCOLOGY HOLDINGS INC | $ALXO | Shantharam Harish | Chief Financial Officer | A | Employee Stock Option (right to buy) | 125000 | $0.00 | 125,000.0000 | 53,384,145 | 9999.99% | 0.23% |
| Jan. 21, 2025 | ALX ONCOLOGY HOLDINGS INC | $ALXO | Shantharam Harish | Chief Financial Officer | A | Employee Stock Option (right to buy) | 600000 | $0.00 | 600,000.0000 | 0 | 9999.99% | 0.00% |